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Abstract
During salamander limb regeneration, nerves provide signals that induce the forma-
tion of a mass of proliferative cells called the blastema. To better understand these
signals, we developed a blastema−dorsal root ganglia (DRG) co-culture model
system to test the hypothesis that nerves differentially express genes in response to
cues provided by the blastema. DRG with proximal and distal nerve trunks were
isolated from axolotls (Ambystoma mexicanum), cultured for 5 days, and subjected
to microarray analysis. Relative to freshly isolated DRG, 1541 Affymetrix probe
sets were identified as differentially expressed and many of the predicted genes are
known to function in injury and neurodevelopmental responses observed for mam-
malian DRG. We then cultured 5-day DRG explants for an additional 5 days with
or without co-cultured blastema cells. On day 10, we identified 27 genes whose
expression in cultured DRG was significantly affected by the presence or absence
of blastema cells. Overall, our study established a DRG−blastema in vitro culture
system and identified candidate genes for future investigations of axon regrowth,
nerve−blastema signaling, and neural regulation of limb regeneration.
Keywords
Axolotl, blastema, dorsal root ganglia, limb regeneration, Mexican axolotl, nerve
Introduction
Salamanders and humans have structurally homologous
tetrapod limbs, but only in salamanders is this structure
capable of regeneration. When salamanders lose parts of
their limbs from injuries, cells adjacent to the injury site
are recruited to form a mass of proliferative mesenchymal
cells called the blastema. The blastema grows and eventually
becomes a self-organizing structure that provides progen-
itor cells for regrowth and patterning of the missing limb
(McCusker and Gardiner 2013). One of the earliest discov-
eries of an essential regulator of the process of blastema
formation and subsequent limb regeneration was that sever-
ing the nerve supply either “retarded or entirely prevented”
limb regeneration (Todd 1823). More than a century and a
half later, researchers are still looking for the elusive fac-
tor(s) that the nerve provides in order to exert its effect on
regeneration. Over the years many putative factors have been
investigated, and now with the availability of new techniques
and genomic resources it is possible to identify specific gene
regulatory networks associated with this phenomenon.
Shortly after limb amputation, nerve fibers regenerate
and grow distally into the injured limb tissues where they
interact with the newly healed wound epithelium (Singer
1949; Thornton and Thornton 1970; Satoh et al. 2008).
Singer (1978) proposed that these regenerating nerves supply
trophic factors (referred to in the regeneration literature as
“neurotrophic factor(s)”) independent of electrical transmis-
sion that support blastema cell proliferation during the early
and mid phases of regeneration. Several molecules have been
proposed as the putative nerve-derived trophic factors, in-
cluding fibroblast growth factors (FGF) (Mullen et al. 1996;
Satoh et al. 2008), substance P (Globus et al. 1991), neureg-
ulin (Wang et al. 2000), and transferrin (Mescher et al. 1997).
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Nerve-derived signals in theory could stimulate blastema cell
proliferation either directly or indirectly by signaling to non-
neuronal cells of the nerve sheath to release trophic factors.
For example, anterior gradient protein 2 (agr2) is expressed
in Schwann cells but not in neurons, and can rescue regener-
ation of partially innervated newt limbs (Kumar et al. 2007).
Similarly, the early wound epithelium (WE) and later api-
cal epithelial cap (AEC) appear to be direct targets of nerve
signaling (Satoh et al. 2008, 2012) and they could signal sec-
ondarily to the underlying mesenchymal cells; for example,
FGF8 produced in the WE/AEC would stimulate blastema
cell proliferation as it does in developing limb buds (Han et
al. 2001).
Several properties of the neurotrophic factor(s) have been
identified over many decades of research. In the case of sen-
sory neurons, the factor is thought to be produced in the cell
bodies located in the dorsal root ganglia (DRG), transported
distally along nerve fibers and released distally at sites where
the sensory fibers interact with basal keratinocytes of the WE
(Wallace 1972; Scadding 1988; Kiffmeyer et al. 1991; Satoh
et al. 2008, 2012). The factor(s) is produced by sympathetic,
motor, and sensory nerves innervating the limb (Singer 1952,
1974), as well as by the spinal cord (Boilly and Albert 1988),
brain (Singer et al. 1976), and eye (Pietsch and Webber 1965).
Finally, a critical threshold of nerve fibers is necessary for
the limb to regenerate, such that if the number of nerve fibers
innervating the limb is greater than this threshold, the limb
will regenerate. Conversely, if the number of fibers is ex-
perimentally reduced below this threshold, the limb fails to
regenerate (Singer 1952).
The properties above suggest that the neural signaling fac-
tor is transcribed by sensory neurons whose cell bodies are
located in DRG (e.g., Satoh et al. 2008). How these cells
respond to injury resulting from amputation as well as their
subsequent interactions with cells of the regenerating limb
blastema is complex. Initially, a nerve responds to and recov-
ers from axotomy, a process that occurs during the first few
days following amputation (Singer 1952). During this phase
of regeneration, it is likely that genes encoding proteins nec-
essary for cell survival, apoptosis, and neural development
are transcribed. As axons regrow and re-innervate tissues, it is
also likely that the regenerating nerves respond to, as well as
signal to, the target tissues in the blastema. Consistent with
this model of bi-directional signaling between nerves and
blastema cells (both mesenchymal cells and keratinocytes of
the WE/AEC) is the observation that, when DRG or spinal
cord explants are co-cultured with blastemas, there is an en-
hanced outgrowth of axons that orient towards the blastema
(Bauduin et al. 2000; Tonge and LeClere 2000; Dmetrichuk et
al. 2005). This response to the presence of a blastema in vitro
suggests that a similar signaling mechanism operates in vivo
to modulate transcription and translation of proteins that en-
hance and direct outgrowth of the regenerating nerve fibers.
Unraveling the complexity of reciprocal nerve−blastema sig-
naling is key to identifying the neurotrophic requirement for
blastema formation and growth. To achieve this goal, we are
developing experimental in vitro models that will allow us to
identify the temporal sequence of regeneration-specific tran-
scriptional responses from both nerves and blastema cells.
In this study we focused on the response of regenerat-
ing DRG neurons and associated cells to signaling from the
blastema. To do this, we modified the in vitro DRG−blastema
co-culture model of Tonge and LeClere (2000) to test the hy-
pothesis that signaling from blastema cells regulates gene
transcription by cells within the regenerating nerve. We iso-
lated DRG along with their proximal and distal nerve trunks
from axolotls (Ambystoma mexicanum), and cultured them in
the presence or absence of explanted medium bud blastemas.
Since the nerve is composed of many different cell types in-
cluding Schwann cells, fibroblasts, and endothelial cells in
addition to the neurons, we have identified changes in gene
expression in the nerve as a whole. This reflects the situation
in vivo in which all these cell types could potentially interact
with and respond to signals originating from the blastema.
We discovered that more than 1500 genes change expression
in DRG and the nerve trunk during the first 5 days of cul-
ture, during which time the explanted DRG heal and begin
to regenerate. After an additional 5 days of culture, a much
smaller group of 27 genes were expressed differentially by
DRG in response to the presence of co-cultured blastema
cells.
Results
Culture of dorsal root ganglia and
blastema explants
Most DRG explants survived after surgical excision and be-
gan to regenerate axons after about 24 h in culture (Fig. 1A).
Initially, a few growing neurites were observed to be extend-
ing from the distal cut end of the nerve, and over the next
several days of culture, increasing numbers of neurites were
observed (Fig. 1B). Explants that did not exhibit initial neu-
rite outgrowth at 24 h or exhibited continued outgrowth at 5
days were discarded and not used in the experiments.
In addition to regenerating neurites, the morphology of
DRG (that were used experiments) appeared normal in
histological sections (Fig. 1C and E). 4’,6-Diamidino-2-
phenylindole (DAPI) stained nuclei within both the DRG and
the distal nerve trunk appeared normal with little evidence
of pyknosis (Fig. 1E). Cells within both the DRG and the
nerve trunk were proliferating as evidenced by the presence
of 5-ethynyl-2′-deoxyuridine (EdU) positive nuclei (green).
Proliferation of cells within both the DRG and the nerve
trunk in response to peripheral nerve injury in vivo has been
reported previously (Clemence et al. 1989; Zochodne 2012).
Neurites were present in the nerve trunk in DRG explants that
were cultured either alone (Fig. 1E) or in association with
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Figure 1. Axolotl dorsal root ganglia (DRG) in vitro. (A) A bright field image of a DRG in vitro 24 h after being explanted. Regenerating neural
projections (arrows) are observed at the transected end of the nerve trunk. (B) Image of the same DRG after 4 days of culture in vitro. Neurite
outgrowth (arrow) from the cut end of the nerve trunk was robust. (C) Fluorescent image of a sagittal section of a DRG−blastema co-culture.
The blastema was placed on the distal cut end of the DRG with the proximal region of the blastema coming into contact with the regenerating
neurites. Nerve fibers were visualized by immunostaining of acetylated α-tubulin (red), and cell nuclei were stained with 4’,6-diamidino-2-
phenylindole (DAPI) (blue). Proliferating cells were detected with 5-ethynyl-2′-deoxyuridine (EdU) (green). (D) Diagram of DRG−blastema
co-culture set-up. The DRG and blastema were adhered to the bottom of the cell culture insert with a drop of growth factor reduced matrigel.
(E) Immunofluorescence image of a longitudinal section of a DRG in vitro. The DRG was adhered to the cell culture with matrigel. Phosphorylated
neurofilaments were visualized by immunostaining with RT97 (red). Cell nuclei were stained with DAPI (blue). Proliferating cells were detected
with EdU (green). Scale bars 0.5 mm.
blastema explants (Fig. 1C) as evidenced by the presence
of phosphorylated neurofilaments (stained with the NRT97
antibody, red). The appearance of the NRT97-positive neu-
rofilaments within cultured axolotl DRG was similar to what
has been reported previously for injured peripheral nerves in
vivo (Lawson et al. 1984; Bergman et al. 1999). Thus, axolotl
DRG appear to be viable and morphologically comparable
to DRG in vivo, as has been reported previously (Tonge and
LeClere 2000),
After 5 days of culture in vitro, DRG that appeared healthy
with extensive neurite outgrowth were selected for co-culture
with explanted medium bud stage blastemas (Fig. 1D).
As with the explanted and cultured DRG, the blastema cells
appeared healthy. Most nuclei appeared normal when ob-
served in DAPI stained tissue sections, and blastema cells
continued to proliferate as evidenced by the incorporation of
EdU (Fig. 1C). Studies to further characterize the response of
explanted blastema cells to culture conditions and to signals
from DRG are in progress.
Differentially expressed genes identified
from in vitro cultured DRG
A total of 1541 probe sets were identified as differently ex-
pressed between DRG at the time of removal from the donor
animal (day 0) and DRG that had been cultured in vitro
for 5 days (Figs. 2, 3 and Table S1). Of this total, 1498
probe sets showed significant sequence identity to human
RefSeq proteins (E ≤ 1 × 10−7) and we considered these
to be salamander−human orthologous genes in the enrich-
ment analyses described below. We note that >60 of these
genes were identified by two to four independent probe sets.
Thus, overall, statistical significance was validated for ap-
proximately 5% of the differentially expressed genes.
The majority of these probe sets (N = 979) presented
higher transcript abundances at day 5 than day 0, a pattern
indicating that expression of the corresponding genes was
upregulated in response to injury (Fig. 2 and Table S1). For
many of the genes associated with these probe sets, the mag-
nitude of the change was dramatic, with 135 showing more
than a 5-fold increase in expression (Table S1). Of these up-
regulated genes, many are known to function in the regula-
tion of inflammatory and innate immune responses (e.g., lep,
il8, il1b, tgfb1, irf1, thbs1, mdm2, hmox1). Similarly, genes
associated with cellular growth and developmental regula-
tion (e.g., bdnf, ctgfntf3, gadd45b, gadd45g) and axon de-
velopment and regrowth (e.g., bmp2, smad1, creb1, bcl2l1,
ankrd1, npy, robo1) were upregulated. A number of over-
represented biological process and Panther protein class on-
tology terms were identified based on genes that presented
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Figure 2. Venn diagram showing the number of upregulated, dif-
ferentially expressed genes identified between time and treatment
contrasts. Substantially more genes were identified as differentially
expressed between day 0 and day 5 cultured dorsal root ganglia
(DRG) than between day 10 DRG with blastema (10 B) and day 10
DRG without blastema (10 NB).
Figure 3. Venn diagram showing the number of downregulated, dif-
ferentially expressed genes identified between time and treatment
contrasts. Substantially more genes were identified as differentially
expressed between day 0 and day 5 cultured dorsal root ganglia
(DRG) than between day 10 DRG with blastema (10 B) and day 10
DRG without blastema (10 NB).
higher transcript abundances at day 5 than day 0 (Table 1).
These included immune system processes, RNA and nucleic
acid metabolic processes, as well as the MAPKKK signal-
ing cascade that were identified as significantly enriched bi-
ological processes. Also, several RNA protein class gene
ontologies were identified as significant, including mRNA
processing factor and RNA/ribonucleoprotein binding
protein (Table 1).
Table 1. List of statistically significant (P < 0.05) over-represented bi-
ological process (BP) and Panther protein class (PC) ontology terms
for genes identified as differentially expressed in axolotl dorsal root
ganglia between day 0 and day 5 of culture in vitro.
Upregulated at day 5 Observed Expected
Nucleobase, nucleoside,
nucleotide and nucleic acid
metabolic process: BP
193 118
RNA metabolic process: BP 61 22
mRNA processing 42 14
Nuclear mRNA splicing, via
spliceosome: BP
34 10
Metabolic process: BP 343 283
Primary metabolic process: BP 326 268
MAPKKK cascade: BP 24 9
Response to stimulus: BP 52 30
Immune system process: BP 74 48
RNA binding protein: PC 85 40
Nucleic acid binding: PC 151 92
Ribonucleoprotein: PC 16 4
mRNA processing: PC 21 8
Downregulated at day 5
Muscle contraction: BP 16 5
Cytoskeletal protein: PC 36 15
Extracellular matrix structural
protein: PC
8 1
Actin family cytoskeletal protein:
PC
20 8
In terms of genes that were downregulated (N = 562),
only muscle contraction was identified as a statistically en-
riched biological process (Table 1). Downregulated genes
associated with cytoskeletal and extracellular matrix pro-
tein classes were also identified as statistically enriched. As
was observed for upregulated genes, some of the downregu-
lated genes are well-established regulators of cellular growth
and development (gas6 and kit). In addition, Schwann cell
biomarkers (pmp22, mbp, plp1, gfap) showed lower tran-
script abundances at day 5 relative to day 0. The results
indicate that, after DRG are excised and cultured for 5 days,
transcript abundances change for >1500 genes. The pre-
dicted functions for these differentially expressed genes are
consistent with the conclusion that cultured DRG mount
robust injury and neurodevelopmental responses, including
changes in cytoskeletal structure, the extracellular matrix,
and RNA processes associated with transcriptional and post-
transcriptional regulation.
Effect of blastema cell co-culture on DRG
transcription
We compared transcript abundance estimates between the
two day 10 treatments (DRG co-cultured with blastema cells
or DRG cultured alone from day 5 to day 10). A total
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of 27 genes were identified as differentially expressed in
DRG in response to the presence of a co-cultured blastema
(Table 2). Of these differentially expressed genes, 16 probe
sets registered significantly higher transcript abundances
in DRG−blastema co-cultures. Eleven of these have pre-
dicted gene names: areg, krt15, krt17, mall, cryba2, c3orf54,
col22A1, marcks, chd3, kazald1, and tacc3. A total of 11
probe sets registered lower transcript abundances in DRG
that were co-cultured with a blastema—abat, smc2, znf697,
gas6, napa, idh3g, dnm1l, ndc80, asap1, esco2—and one
unannotated probe (probe set ID axo25121). Of these 27
probe sets, the greatest expression difference was observed
for krt17 and axo31729-f, which were expressed 7.8- and
4.2-fold higher respectively in response to the presence of a
co-cultured blastema. These results show that the presence of
a blastema affected transcription of relatively few but poten-
tially important genes that are expressed by cultured DRG.
We did not observe differences in the level of expression
of the blastema marker genes prrx1, msx2, and hoxa13 be-
tween DRG samples with or without co-cultured blastemas,
indicating that blastema cells did not contaminate the DRG
samples.
Discussion
An unresolved question in regeneration biology concerns
the nature of the functional relationship between nerves and
blastema cells. It is well documented that nerves are required
for limb regeneration in salamanders, and consequently most
regeneration studies have focused more on the signals that
nerves may be providing (referred to in the regeneration lit-
erature as neurotrophic factor(s)) rather than the signals that
the blastema provides to induce and guide the regeneration
of the nerve (Globus et al. 1991; Mullen et al. 1996; Mescher
et al. 1997; Wang et al. 2000; Satoh et al. 2008). In order to
identify the genes involved in this reciprocal interaction, we
have been working to develop a nerve (DRG) and blastema
co-culture model. In this study we have used this model to
test the hypothesis that blastema cells provide signals that
regenerating nerves respond to. By culturing DRG we ana-
lyzed the transcriptional response not only of the neurons,
but also the Schwann cells, fibroblasts, and other cells that
are found in the nerve trunk that may be functionally impor-
tant for the interaction between the nerve and the blastema
in vivo. We observed that dissection and culture of DRG
initiates dramatic changes in transcription after 5 days of
in vitro culture that are consistent with the conclusion that
nerves are recovering from injury and beginning to regen-
erate. At that point, the regenerating nerves respond to the
presence of co-cultured blastema cells and differentially ex-
press a relatively small number of genes that are targets
for future functional studies. Below, we highlight several
genes that code for proteins that are likely to be associated
Table 2. Probe sets registering significant fold changes in transcript
abundances for dorsal root ganglia (DRG)−blastema co-cultures.
Fold change is measured as the ratio of day 10 DRG cultured with a
blastema compared with day 10 DRG cultured without a blastema.
Probe sets that are unannotated are displayed as the probe set ID
with the prefix “axo”.
Upregulated at day 10 Fold change P-value
Keratin 17 7.82 2.44E-05
axo31729-f 4.21 1.25E-04
Kazal-type serine peptidase inhibitor
domain 1 precursor
3.14 4.47E-03
axo31698-f 2.68 3.90E-05
Mal, T-cell differentiation protein-like 2.52 1.02E-03
Amphiregulin preproprotein 2.19 1.15E-03
Keratin 15 2.11 2.64E-03
axo31329-f 1.74 8.87E-05
Myristoylated alanine-rich protein
kinase C substrate
1.44 9.77E-03
Crystallin, beta A2 1.42 1.76E-03
axo28274-f 1.39 1.85E-03
Similar to collagen, type XXII, alpha 1 1.39 8.02E-03
CPEB-associated factor Maskin 1.37 4.38E-03
Chromodomain helicase DNA binding
protein 3 isoform 1
1.36 1.01E-02
axo30442-f 1.28 4.22E-03
Hypothetical protein LOC389119 1.28 1.18E-02
Downregulated at day 10
N-ethylmaleimide-sensitive factor
attachment protein, alpha
1.79 5.72E-03
Establishment of cohesion 1 homolog 2 1.69 1.24E-02
Kinetochore associated 2 1.64 7.51E-03
Structural maintenance of
chromosomes 2
1.63 1.81E-04
Development and differentiation
enhancing factor 1
1.57 3.26E-03
4-Aminobutyrate aminotransferase
precursor
1.57 2.15E-03
Isocitrate dehydrogenase 3 (NAD+)
gamma isoform a precursor
1.53 6.86E-03
Zinc finger protein 697 1.52 1.11E-02
axo25121-f 1.48 3.30E-03
Dynamin 1-like isoform 3 1.42 2.21E-03
Growth arrest-specific 6 isoform 1 1.31 1.17E-02
with cell growth and development, axon regrowth, and limb
regeneration.
Transcriptional analysis of limb
regeneration processes using cultured
salamander DRG
Salamanders are unique because they provide an opportunity
to understand how tissues can be regenerated endogenously.
If a salamander’s limb or tail is amputated, this regeneration
program is activated and the missing structures are regen-
erated. However, salamander regeneration is complex from
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a transcriptional perspective (e.g., Monaghan et al. 2007,
2009), involving thousands of gene expression changes. Ac-
cordingly, there is need to develop in vitro models that reduce
the complexity of tissue regeneration and allow for an un-
derstanding of how the various tissues and cells respond to
injury and pro-regenerative signaling. The nerve (DRG) and
blastema co-culture model described here was utilized to
test the hypothesis that there is reciprocal signaling between
blastema cells and cells in the peripheral nerve that results
in the differential transcription of genes required for limb
regeneration.
Although there were specific changes in gene expression
associated with interactions between DRG and blastemas,
it is not known whether they occurred as a consequence of
axonal retrograde transport of molecules from the blastema
to DRG neuron cell bodies. It is possible that blastemas af-
fected DRG transcription indirectly, for example via release
of diffusible molecules such as retinoic acid (Scadding and
Maden 1994; Prince and Carlone 2003.) and not via axon
transport. Related to this question is the fact that the DRG
consist of several different cell types (e.g., neurons, Schwann
cells, fibroblasts, immune cells, and cells associated with
the vasculature), and we do not have data indicating which
specific cell types are involved in the observed transcrip-
tional changes (e.g. in situ hybridization). The diversity of
the gene expression responses that we observed is consis-
tent with the conclusion that multiple cell types are involved
in the response. For example, we observed a significant de-
crease in expression of Schwann-cell-associated transcripts
(pmp22, mbp, plp1) after 5 days of in vitro DRG culture, sug-
gesting either transcriptional repression of myelin-associated
proteins or progressive Schwann cell death. Similarly, cul-
tured salamander DRG recapitulate transcriptional changes
observed after mammalian sciatic nerve injury (Newton et
al. 2000; Kubo et al. 2002; Xiao et al. 2002; Tanabe et al.
2003; Boeshore et al. 2004; Nilsson et al. 2005; Bosse et al.
2006; Stam et al. 2007), indicative of responses from im-
mune cells (genes associated with inflammation) and from
neurons (genes associated with nerve development and ax-
onal regrowth).
Candidate genes associated with axon
regrowth and blastema cell proliferation
The DRG−blastema co-culture model (in vitro) was de-
signed to correspond to the time during limb regeneration
when nerves have recovered from the injury of amputation
and begun to function in the recruitment of proliferating
blastemal cells (in vivo). To model this phase of regenera-
tion, blastemas were placed in contact with neurites that had
sprouted from the peripheral branch after 5 days of culture.
Historically, nerve−blastema signaling has been modeled as
a process where axons release molecules that directly stim-
ulate blastema cell proliferation. However, nerve signaling
may be indirect, with axons signaling wound epithelial cells,
epithelial glands, or Schwann cells to secrete molecules to
support blastema cell proliferation (Kumar et al. 2007, 2010;
Satoh et al. 2012). We note that whether signaling occurs
directly or indirectly, axon regrowth is a necessary first step
in the genesis of the trophic effect required for blastema
maturation, and axon regrowth after nerve injury requires
transcription (Smith and Skene 1997).
In our study, DRG culture elicited a diverse transcrip-
tional response involving many of the same gene expression
changes observed in previous studies of cultured mammalian
DRG as well as in DRG with axotomized peripheral nerves
(Boeshore et al. 2004; Nilsson et al. 2005; Szpara et al. 2007).
The vast majority of genes that were differentially expressed
in cultured salamander DRG (compared with day 0) were
expressed similarly in the presence or absence of a blastema.
Thus, blastema co-culture had a relatively minor effect on
the overall DRG injury response program. Of the genes that
were differentially expressed as a function of blastema co-
culture, several are predicted to regulate cellular growth and
axon regrowth. The differentially expressed gene that exhib-
ited the largest change in expression (up-related in response
to co-cultured blastemas) was keratin 17 (krt17), which is
rapidly induced in response to injury via the Akt/mTOR sig-
naling pathway in mammals (Kim et al. 2006). Activation of
the mTOR pathway after peripheral injury of murine DRG
neurons is associated with axon regrowth and target inner-
vation (Abe et al. 2010). Since krt17 generally is associated
with epithelial cells and appendages in mammals, and not
DRG, further analysis of its regulation during axolotl re-
generation is needed to determine its possible function in
nerve−blastema interactions.
It is generally thought that the nerve requirement for limb
regeneration is a consequence of one or a few trophic factors
that are synthesized and secreted by nerves as they innervate
the blastema niche (blastema cells and the overlying apical
epithelium). Studies over the years have identified several
characteristics of these presumptive trophic factors: they are
secreted peptides or proteins; they are produced by sensory,
motor, and autonomic nerves; they increase in level/activity
in regenerating axons and after priming/conditional lesions;
and they stimulate mitosis (Singer 1952; Kamrin and Singer
1959; Lebowitz and Singer 1970; Deck 1971; Globus and
Liversage 1975; Singer et al. 1976; Globus and Vethamany-
Globus 1977; Choo et al. 1978; Carlone and Foret 1979;
Boilly and Baudin 1988). We observed that expression of
several trophic factors and neuropeptides increased signifi-
cantly in cultured DRG whether or not they were co-cultured
with a blastema (ntf3, batf3, npy, bdnf, npff, nts, ctgf). Kumar
et al. (2010) reported that ectopic expression of agr2 rescues
limb regeneration in partially innervated newt limbs, and ex-
pression is associated with Schwann and Leydig cells in the
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epidermis. We did not observe significant changes in agr2
expression; however, a potential downstream target of agr2,
areg (Dong et al. 2011), was upregulated modestly, but not
significantly (∼1.5-fold, P = 0.03), between day 0 and day
5 of culture, and then was expressed at a significantly higher
level in DRG−blastema cultures compared with DRG cul-
tured without a blastema. In mouse DRG, areg is one of the
most highly upregulated genes in response to sciatic nerve
transection and application of AREG to DRG cultures in-
duces neurite outgrowth (Nilsson et al. 2005). As a member
of the epidermal growth factory family, areg is a mitogen for
Schwann cells and fibroblasts; the latter cell type gives rise to
the majority of cells in the early axolotl blastema (Muneoka
et al. 1986). Finally, areg is secreted by neurons and Schwann
cells (Kimura et al. 1990) and thus could be produced locally
at the wound site or in neural cell bodies and transported to
blastema cells via regenerating nerves. Thus areg is a strong
candidate for functioning as a neurotrophic factor given its
pleiotropic potential to stimulate axon regrowth as well as
blastema cell proliferation.
Our study identified kazald1 as a second gene with prop-
erties that would be expected of a trophic factor that could
stimulate proliferation of blastema cells. Kazald1 expres-
sion was increased 3-fold in day 10 DRG−blastema co-
cultures compared with day 10 DRG without blastemas.
Kazald1 is a secreted member of the insulin growth fac-
tor binding protein family that is transcriptionally upregu-
lated during the early phase of bone formation and regen-
eration, and it is associated with proliferation of osteoblasts
(Shibata et al. 2004).
Expression of a third signaling factor, bmp2, was upreg-
ulated 1.5-fold in response to co-culture with a blastema
(with a P-value of 0.015 which was greater than the cutoff
of 0.0125 for genes listed in Table 2). Bmp2 was signifi-
cantly upregulated (nearly 3-fold) during the initial period
in culture (days 0−5) and its expression continued to in-
crease when co-cultured with a blastema. Members of the
BMP family of growth factors are involved in the regulation
of growth and pattern formation during both limb develop-
ment and regeneration. Recently it has been demonstrated
that ectopic limb blastemas can be induced in axolotls by
treating wounds with a cocktail of BMP and FGF in vivo as a
substitute for signaling from a nerve (Makanae et al. 2013).
Further studies on the role of BMP2 signaling in the regula-
tion of blastema cell proliferation are in progress. Previous
studies demonstrated that expression of keratinocyte growth
factor (Fgf7) is induced in DRG in response to limb ampu-
tation (Satoh et al. 2008). Since a probe set corresponding
to the Fgf7 gene is not present on the Amby 002 GeneChip,
we could not document changes in Fgf7 expression. We did
not observe significant changes in the expression of other
members of the FGF family, including Fgf1, Fgf2, Fgf8 and
Fgf10.
Conclusion
Our results show that a robust transcriptional response is ac-
tivated in cultured axolotl DRG that is comparable to the
responses observed in mammalian DRG explanted into cul-
ture or after transection of peripheral nerves. Co-culture with
a blastema resulted in a low number of potentially important
changes in gene expression in axolotl DRG. At least three
of the differentially expressed genes that we identified en-
code secreted, mitogenic proteins, supporting classical ideas
that nerves may provide one or a few factors that function in
blastema formation and cell proliferation.
Materials and methods
Animal care and collection of DRG and
blastema
The handling and surgical manipulation of axolotls was car-
ried out according to University of California, Irvine (UCI),
Animal Care and Use guidelines. Axolotls (Ambystoma mex-
icanum) measuring 15−20 cm from snout to tail tip were
spawned at UCI or the Ambystoma Genetic Stock Center
at the University of Kentucky. They were housed on a 12h
light/dark cycle and fed ad libitum. DRG were collected post-
euthanasia by surgically removing the spinal nerves that in-
nervated either the forelimb (spinal nerves 3, 4, and 5) or the
hind limb (spinal nerves 15, 16, and 17). The nerves were
severed where the dorsal and ventral nerve roots exit the
spinal cord, and again 3 mm distal to the spinal ganglion.
DRG and limb blastema co-culture
DRG were cultured individually in 12-well Nunc nun-
clon plates with 60% L-15, 5% fetal bovine serum, 1%
Insulin-Transferrin-Selenium, and gentamicin/amphotericin
B (Sigma). Each DRG was attached to the bottom of the
culture well by embedding it in a small drop (about 3 μL) of
growth-factor-reduced BD matrigel (BD Biosciences). Only
DRG explants that exhibited neurite outgrowth within the
first 24 h of culture were used for subsequent experiments.
DRG explants were cultured for 5 days and either collected
for RNA extraction or assigned to two experimental treat-
ments: (1) nerve−blastema co-culture in which a medium
bud blastema was placed directly on top of the regenerating
region of the nerve, or (2) nerve culture without a co-cultured
blastema.
For the samples in which the DRG were co-cultured with
blastemas, we collected blastemas at the medium bud stage
of regeneration from limbs that had been amputated several
days earlier. The apical epithelium (AEC) was not removed
prior to placing the blastemas adjacent to the cultured DRG
such that the proximal cut end of the blastema covered newly
sprouted neurites that were regenerating from the distal cut
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end of the DRG (Fig. 1C and D). The DRG and blastema
were secured together with a small drop of growth-factor-
reduced matrigel. For the DRG cultures without a blastema,
procedures were the same as for the cultures with an added
blastema, including removal of the medium, touching the
surrounding matrigel with forceps, adding a drop of matrigel
as described above, and then refilling the well with culture
medium. Explants were cultured for an additional 5 days re-
sulting in a total of 10 days in vitro after excision of the DRG
from the donor animal. At 10 days of culture, the co-cultured
DRG were separated from the associated blastemas under a
dissecting microscope to prevent blastema cell contamination
and were collected for RNA extraction. A total of 15 DRG
were pooled for each biological replicate and three replicates
were analyzed at both the day 5 and day 10 time points. Three
replicate control samples (day 0) were prepared by pooling
non-cultured DRG (12 per replicate) collected directly from
euthanized salamanders.
RNA isolation and microarray analysis
DRG were pooled within biological replicates prior to RNA
isolation. RNA was isolated using Trizol (Invitrogen) in con-
junction with the Nucleospin RNA XS Kit (Macherey-Nagel)
following the manufacturer’s protocol. RNA quality was
assessed using an ND-1000 spectrophotometer (Nanodrop;
Wilmington, DE) and a Bioanalyzer 2100 (Agilent; Santa
Clara, CA). The 12 RNA samples that were obtained from
the day 0, day 5, and day 10 treatments were analyzed using
the Amby 002 GeneChip (Huggins et al. 2012). The Univer-
sity of Kentucky Microarray Core Facility generated biotin
labeled cRNA targets for all samples and hybridized each to
independent GeneChips. The GeneChips were scanned and
processed using the RMA algorithm in Affymetrix’s Expres-
sion Console software (Affymetrix, Santa Clara, CA).
Statistical analysis of gene expression
Prior to statistical analyses, probe sets with low and variable
expression values were filtered. Probe sets were filtered if
they registered expression values below the maximum bot-
tom quartile value (4.27 across all arrays) for one or more
replicate arrays within a treatment. To identify differentially
expressed genes, data were analyzed using one-way ANOVA
as implemented in JMP Genomics version 5.0 (SAS Insti-
tute, Cary, NC) and a significance cutoff of FDR = 0.05
(Benjamini and Hochberg 1995). Follow up t-tests were used
to detect significantly different changes in gene expression
after the initial 5-day period of DRG culture (day 0 vs. day
5) and between DRG cultured with and without blastemas at
day 10, using a P-value cutoff of 0.0125.
We used Panther (Thomas et al. 2003; Mi and Thomas
2009) to identify gene ontology terms that were statistically
enriched in our lists of differentially expressed genes. All
of the genes on the Ambystoma GeneChips with established
orthologies to human protein coding sequences were used to
generate expected values. We retained all over-represented
terms that were supported by >2 counts at a Bonferroni-
adjusted α of 0.05.
Immunohistochemistry
Tissues were fixed for 3 h at room temperature in 4%
paraformaldehyde and were then dehydrated in graded
alcohol followed by xylene, embedded in paraplast, and
sectioned at 5 μm. To perform immunohistochemistry sec-
tions were de-paraffinized and rehydrated in Tris Buffered
Saline with Tween (TBST). Sections were then incubated
with anti-acetylated α-tubulin (Abcam, diluted 1:250) and
anti-RT97 (DSHB, diluted 1:250) overnight at 4◦C. Sections
were washed with TBST and incubated with anti-mouse 594
(Abcam, diluted 1:250). Following secondary antibody treat-
ment sections were washed with TBST and mounted with
ProLong Gold Antifade with DAPI. To label proliferating
cells, 80 μmol/L of 5-ethynyl-2′-deoxyuridine (EdU) was
added to culture media for 5 h. Following EdU labeling, tis-
sues were processed as described above. Proliferating cells
were then visualized using the Click-It-EdU Alexa-Fluor 488
kit (Life Technologies).
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